|
 |
 |
 |
 |
|
A 71-year-old woman with decreased vision, nyctalopia, and peripheral vision loss
Digital Journal of Ophthalmology 2016 Volume 22, Number 4 December 31, 2016 DOI: 10.5693/djo.02.2016.06.001
|
Printer Friendly
Download PDF |
|
Ravi Parikh, MD, MPH | Department of Ophthalmology and Visual Science, Yale University, New Haven, Connecticut Miguel A. Materin, MD | Department of Ophthalmology and Visual Science, Yale University, New Haven, Connecticut; Smilow Hospital at Yale New Haven Hospital Robert Lesser MD | Eye Care Group, New Haven, Connecticut Joachim Baehring, MD, PhD | Smilow Hospital at Yale New Haven Hospital; Department of Neurology, Yale University, New Haven, Connecticut Mario Sznol, MD | Smilow Hospital at Yale New Haven Hospital; Department of Internal Medicine, Yale University, New Haven, Connecticut Jennifer A. Galvin MD | Department of Ophthalmology and Visual Science, Yale University, New Haven, Connecticut
|
|
References | 1. Hooks JJ, Tso MS, Detrick B. Retinopathies associated with antiretinal antibodies. Clin Diagn Lab Immunol 2001; 8:853-8.
2. Goldstein SM, Syed NA, Milam AH, Maguire AM, Lawton TJ, Nichols CW. Cancer-associated retinopathy. Arch Ophthalmology 1999;117:1641-5.
3. Lu Y, Jia L, He S, et al. Melanoma-associated retinopathy: a paraneoplastic autoimmune complication. Arch Ophthalmology 2009;127:1572-80.
4. Myers DA, Bird BR, Ryan SM, et al. Unusual aspects of melanoma. Case 3. Melanoma-associated retinopathy presenting with night blindness. J Clinical Oncology 2004;22:746-8.
5. Grewal D, Fishman GA, Jampol LM. Autoimmune retinopathy and antiretinal antibodies: a review. Retina 2014;34:827-45.
6. Borkowski, LM, Grover S, Fishman GA, Jampol LM. Retinal findings in melanoma-associated retinopathy. Am J Ophthalmol 2001;132:273-5.
7. Lei B, Bush RA, Milam AH, Sieving PA. Human Melanoma Associated Retinopathy (MAR) antibodies alter retinal-ON response of the monkey ERG in vivo. Invest Ophthalmol Vis Sci 2000;41:262-6.
8. Guy J, Aptsiauri N. Treatment of paraneoplastic visual loss with intravenous immunoglobulin. Arch Ophthalmol 1999;127:612-4. | |
|
 |
 |
 |

|
|